- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02600078
The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure
Study Overview
Status
Conditions
Detailed Description
Introduction: Hypoxia is the reduction in partial pressure of oxygen that occurs with exposure to altitude. Individuals acclimatize at different rates and to different degrees meaning that those who are slow to make the necessary physiological adjustments will develop signs and symptoms of acute mountain sickness (AMS). AMS is marked by headache, gastrointestinal disturbances, insomnia, fatigue and ataxia, which can be evaluated using subjective questionnaires such as the Lake Louise Score (LLS). Evaluation of AMS by solely using subjective questionnaires can make differential diagnosis of other possible pathologies difficult. Ataxia is characterized by poor coordination in the absence of significant weakness. Ataxia can be assessed with the performance of a coordinated task. The investigators have developed a novel finger-tapping task on a mobile device to assess both reaction time and accuracy. The proposed research will evaluate the utility of this tool in assessing human acclimatization to hypoxia, which could ultimately serve as a novel, objective methodology in the diagnosis of AMS.
Hypothesis: (1) When exposed to simulated altitude (equivalent to 4200m above sea level), subjects will exhibit diminished coordination relative to a sham exposure. (2) Reaction time of novel coordination tasks will positively correlate with heart rate, balance, and LLS. (3) Accuracy of novel coordination tasks will negatively correlate with heart rate, balance, and LLS.
Methods: A repeated-measures design with a familiarization trial, a hypoxic trial, and a sham trial will be used. Sixteen healthy adults will be exposed to normobaric hypoxia in the investigator's chamber, simulating an elevation of 4200m above sea level. Subjects will be measured for pulse oxygen saturation, heart rate, and will complete the LLS, the Balance Error Scoring System (BESS), as well as two electronic finger tap coordination tasks prior to, and at 5 minutes, 4, and 12 hours into the altitude chamber exposure.
Outcomes: This research will enhance the investigators understanding of the relationship between coordination, balance, and acclimatization to hypoxia. It will allow us to validate a new objective tool in the measurement of acclimatization with exposure to hypoxia.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Environmental Physiology Laboratory
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Both Male and Female Gender
- Minimum Age of 18 years
- Maximum Age of 45 years
- Have not traveled to an altitude of 3000m or higher in 3 months prior to testing
- No history of migraines or concussion
- Not Smokers
- Females must be using monophasic birth control
- Not easily claustrophobic
- English Speaking
Exclusion Criteria:
- Non-English speaking individuals
- Subjects younger than 18 years old or older than 45 years old
- Subjects who visit an altitude of 3000m or greater within three months prior to the study
- Subjects with a history of cardiovascular or pulmonary conditions such as; uncontrolled congestive heart failure, COPD, pulmonary hypertension, or sickle cell disease
- Subjects with a history of migraines or concussion
- Smokers
- Females not using monophasic birth control pills
- Subjects experiencing withdrawal symptoms due to abstinence from caffeine
- Easily claustrophobic individuals
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Moderate Hypoxia
Subjects will be exposed to moderate hypoxia and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
|
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.
|
|
Sham Comparator: Sham
Subjects will be exposed to sham and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
|
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.
|
|
Active Comparator: Mild Hypoxia
Subjects will be exposed to mild hypoxia and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
|
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in score of a coordination test.
Time Frame: Coordination test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Coordination test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in severity of symptoms based on questionnaire.
Time Frame: Symptoms questionnaire will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Symptoms questionnaire will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
|
Change in score of a balance test.
Time Frame: Balance test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Balance test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
|
Change in heart rate.
Time Frame: Heart rate will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Heart rate will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
|
Change in pulse oxygen saturation
Time Frame: Pulse oxygen saturation will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Pulse oxygen saturation will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael S Koehle, MD, University of British Columbia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H15-02093
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxia
-
Direction Centrale du Service de Santé des ArméesNot yet recruitingHypoxia | Hypoxia, Brain | Hypoxia in Healthy Individuals | Hypoxia, Altitude | Altitude Hypoxia | Altitude | Hypoxia Altitude Simulation Test | Hypoxia Brain | Normobaric HypoxiaFrance
-
Universite du Littoral Cote d'OpaleNot yet recruitingNormoxia | Intermittent Moderate Hypoxia | Continuous Moderate HypoxiaFrance
-
Western University, CanadaCompletedBrain Hypoxia IschemiaCanada
-
Jorge Torres MejíasEnrolling by invitationChanges in the Intestinal Microbiota Under Hypobaric Hypoxia Conditions | Changes in Blood Glucose Under Hypobaric Hypoxia Conditions | Changes in Body Composition Under Hypobaric Hypoxia Conditions | Determination of Physiological Stress in Hypobaric HypoxiaChile
-
Yale UniversityTianjin Chest HospitalCompletedBrain Ischemia Hypoxia | Muscle; Ischemic | Muscle HypoxiaChina
-
Fliegerärztliches InstitutCompleted
-
University of Texas at AustinCompletedIntermittent HypoxiaUnited States
-
Owlet Baby Care, Inc.Completed
-
Robert L. OwensCompletedIntermittent HypoxiaUnited States
-
Montreal Heart InstituteUniversité de MontréalCompleted
Clinical Trials on AMS Monitor App
-
Boston Scientific CorporationCompletedErectile Dysfunction | ImpotenceUnited States, Canada
-
Scripps Whittier Diabetes InstituteCompletedType 2 DiabetesUnited States
-
Silver Cloud HealthUniversity of Dublin, Trinity College; Berkshire Healthcare NHS Foundation...Completed
-
VA Office of Research and DevelopmentUniversity of Rochester; Northeastern UniversityCompleted
-
ASTORA Women's HealthCompletedPelvic Organ ProlapseUnited States, Belgium, France, Germany, Netherlands, Spain, United Kingdom
-
American Medical SystemsCompletedErectile DysfunctionUnited States
-
University of MinnesotaCompleted
-
Biotronik AGCompletedde Novo Lesions in Native Coronary ArteriesNetherlands, Switzerland, Germany, Belgium
-
LifeScanUnknownDiabetes MellitusUnited States
-
Children's Hospital Medical Center, CincinnatiCompletedCardiac Anomaly | Pectus ExcavatumUnited States